High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2110-5820
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients ; volume:9 ; number:1 ; day:13 ; month:6 ; year:2019 ; pages:1-9 ; date:12.2019
Annals of intensive care ; 9, Heft 1 (13.6.2019), 1-9, 12.2019
- Creator
-
Tanaka, Sébastien
Diallo, Dévy
Delbosc, Sandrine
Genève, Claire
Zappella, Nathalie
Yong-Sang, Jennyfer
Patche, Jessica
Harrois, Anatole
Hamada, Sophie
Denamur, Erick
Montravers, Philippe
Duranteau, Jacques
Meilhac, Olivier
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13613-019-0541-8
- URN
-
urn:nbn:de:101:1-2019112603295495709341
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tanaka, Sébastien
- Diallo, Dévy
- Delbosc, Sandrine
- Genève, Claire
- Zappella, Nathalie
- Yong-Sang, Jennyfer
- Patche, Jessica
- Harrois, Anatole
- Hamada, Sophie
- Denamur, Erick
- Montravers, Philippe
- Duranteau, Jacques
- Meilhac, Olivier
- SpringerLink (Online service)
Other Objects (12)
Association between ethnicity and obesity with high-density lipoprotein (HDL) function and subclass distribution
Effects of particulate matter on atherosclerosis: a link via high-density lipoprotein (HDL) functionality?
Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer
Synthetic high-density lipoprotein (sHDL): a bioinspired nanotherapeutics for managing periapical bone inflammation
Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL) 2 and the larger HDL 3 from very low-density lipoprotein (VLDL)
High-density lipoprotein cholesterol concentration and acute kidney injury after noncardiac surgery
Presepsis biomarker: high-density lipoprotein
Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease
Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)
Loss of sphingosine 1-phosphate (S1P) in septic shock is predominantly caused by decreased levels of high-density lipoproteins (HDL)
Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants
Effect of two lipid-lowering strategies on high-density lipoprotein function and some HDL-related proteins: a randomized clinical trial
Association between ethnicity and obesity with high-density lipoprotein (HDL) function and subclass distribution
Effects of particulate matter on atherosclerosis: a link via high-density lipoprotein (HDL) functionality?
Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer
Synthetic high-density lipoprotein (sHDL): a bioinspired nanotherapeutics for managing periapical bone inflammation
Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL) 2 and the larger HDL 3 from very low-density lipoprotein (VLDL)
High-density lipoprotein cholesterol concentration and acute kidney injury after noncardiac surgery
Presepsis biomarker: high-density lipoprotein
Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease
Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)
Loss of sphingosine 1-phosphate (S1P) in septic shock is predominantly caused by decreased levels of high-density lipoproteins (HDL)
Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants
Effect of two lipid-lowering strategies on high-density lipoprotein function and some HDL-related proteins: a randomized clinical trial
Association between ethnicity and obesity with high-density lipoprotein (HDL) function and subclass distribution
Effects of particulate matter on atherosclerosis: a link via high-density lipoprotein (HDL) functionality?
Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer
Synthetic high-density lipoprotein (sHDL): a bioinspired nanotherapeutics for managing periapical bone inflammation
Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL) 2 and the larger HDL 3 from very low-density lipoprotein (VLDL)
High-density lipoprotein cholesterol concentration and acute kidney injury after noncardiac surgery
Presepsis biomarker: high-density lipoprotein
Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease
Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)
Loss of sphingosine 1-phosphate (S1P) in septic shock is predominantly caused by decreased levels of high-density lipoproteins (HDL)
Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants